The CARRS Cohort is a state-of-the-art, population-based cohort of South Asians to address existing and emerging questions related to cardio-metabolic disease. Since its inception, the CARRS Cohort has grown to follow a diverse population-based sample of more than 20,000 adults living in India, with ongoing follow-up for clinical cardiovascular risk factors, clinical disease, and mortality.
The Precision-CARRS study is a research collaboration between the Centre for Chronic Disease Control (CCDC), New Delhi, Rollins School of Public Health, Emory University, USA, All India Institute of Medical Sciences (AIIMS), New Delhi, Institute of Genomics and Integrative Biology (IGIB), New Delhi, Madras Diabetes Research Foundation (MDRF), Chennai, Sri Ramachandra of Higher Education and Research (SRM), Chennai, Ashoka University, Haryana and University of California, USA.
The overarching goal of the five-year National Institutes of Health (NIH)-USA-funded Precision-CARRS study is to transform the traditional paradigm of cardiovascular disease (CVD) prevention/treatment to one of precision medicine and early-stage detection, to promote cardiovascular health for South Asians.
